Literature DB >> 8503949

Protective effect of 17 beta-estradiol against the cytotoxicity of minimally oxidized LDL to cultured bovine aortic endothelial cells.

A Nègre-Salvayre1, M T Pieraggi, L Mabile, R Salvayre.   

Abstract

The ability of 17 beta-estradiol, progesterone, testosterone and cholesterol in preventing the cytotoxicity of oxidized LDL to cultured aortic bovine endothelial cells (BAEC) was tested and compared. The lipid peroxidation of LDL, promoted either by UV-C radiation, copper ions or cultured human lymphoblastoid cells, was inhibited in a dose-dependent manner by 17 beta-estradiol (IC50 were evaluated at around 50 +/- 10 mumol/l with UV on copper and 6 +/- 2 mumol/l with cells), whereas exogenous cholesterol, progesterone or testosterone were completely inactive under the range of concentrations tested (up to 100 mumol/l). Subsequently, this antioxidant effect of 17 beta-estradiol preventing LDL oxidation protected 'indirectly' BAEC against the cytotoxicity of oxidized LDL. 17 beta-Estradiol was also able to protect 'directly' BAEC against the cytotoxic effect of oxidized LDL (with an IC50 around 0.5 +/- 0.1 mumol/l), whereas the other steroids tested were almost completely inactive. This direct protective effect resulted from an increased resistance of BAEC against the cytotoxic effect of oxidized LDL as shown by pre-incubation of BAEC with 17 beta-estradiol. The protective effect of 17 beta-estradiol was present for 2-3 days. In conclusion, 17 beta-estradiol exhibited an antioxidant activity and was effective in protecting BAEC against the cytotoxicity of oxidized LDL by acting at two separate sites: (i) outside the cells, by inhibiting the LDL oxidation; (ii) inside the cells by increasing the cellular resistance against the cytotoxic effect of oxidized LDL. The potential relevance of these results in relation to prevention of atherogenesis is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8503949     DOI: 10.1016/0021-9150(93)90023-n

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  9 in total

Review 1.  The endosomal-lysosomal system of neurons in Alzheimer's disease pathogenesis: a review.

Authors:  R A Nixon; A M Cataldo; P M Mathews
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

2.  Effects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression.

Authors:  T Caulin-Glaser; C A Watson; R Pardi; J R Bender
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

Review 3.  Gender differences in cardiovascular disease: hormonal and biochemical influences.

Authors:  Faustino R Pérez-López; Luis Larrad-Mur; Amanda Kallen; Peter Chedraui; Hugh S Taylor
Journal:  Reprod Sci       Date:  2010-06       Impact factor: 3.060

4.  Who Should Receive Hormone Replacement Therapy?

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

Review 5.  Estrogens and Parkinson disease: novel approach for neuroprotection.

Authors:  Hideyuki Sawada; Shun Shimohama
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

6.  Overweight and effect of hormone replacement therapy on lipid profiles in postmenopausal women.

Authors:  Hong Sook Ko; Chee Jeong Kim; Wang Seong Ryu
Journal:  Korean J Intern Med       Date:  2005-03       Impact factor: 2.884

Review 7.  Coronary Heart Disease in Postmenopausal Women with Type II Diabetes Mellitus and the Impact of Estrogen Replacement Therapy: A Narrative Review.

Authors:  Marouane Boukhris; Salvatore Davide Tomasello; Francesco Marzà; Sonia Bregante; Francesca Romana Pluchinotta; Alfredo Ruggero Galassi
Journal:  Int J Endocrinol       Date:  2014-07-17       Impact factor: 3.257

8.  Sex hormone-dependent renal cell carcinogenesis induced by ferric nitrilotriacetate in Wistar rats.

Authors:  J Deguchi; M Miyamoto; S Okada
Journal:  Jpn J Cancer Res       Date:  1995-11

9.  Antioxidant and Cytoprotective Properties of Polyphenol-Rich Extracts from Antirhea borbonica and Doratoxylon apetalum against Atherogenic Lipids in Human Endothelial Cells.

Authors:  Jonathan Bonneville; Philippe Rondeau; Bryan Veeren; Julien Faccini; Marie-Paule Gonthier; Olivier Meilhac; Cécile Vindis
Journal:  Antioxidants (Basel)       Date:  2021-12-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.